Seeyond’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.34M Buy
14,606
+3,005
+26% +$1.07M 0.52% 34
2022
Q3
$3.75M Buy
11,601
+1,253
+12% +$397K 0.45% 43
2022
Q2
$3.35M Buy
10,348
+193
+2% +$57.9K 0.38% 53
2022
Q1
$2.91M Sell
10,155
-20
-0.2% -$5.15K 0.29% 81
2021
Q4
$2.81M Sell
10,175
-28
-0.3% -$7.1K 0.26% 91
2021
Q3
$2.36M Sell
10,203
-5,879
-37% -$1.45M 0.23% 123
2021
Q2
$3.69M Sell
16,082
-156
-1% -$31.3K 0.34% 56
2021
Q1
$3.03M Sell
16,238
-2,300
-12% -$450K 0.3% 58
2020
Q4
$3.13M Sell
18,538
-4,759
-20% -$711K 0.32% 52
2020
Q3
$3.45M Buy
23,297
+3,838
+20% +$594K 0.37% 43
2020
Q2
$3.19M Sell
19,459
-1,870
-9% -$287K 0.36% 46
2020
Q1
$79K Sell
21,329
-326
-2% -$44.8K 0.01% 586
2019
Q4
$2.85M Sell
21,655
-6,359
-23% -$737K 0.3% 70
2019
Q3
$3.13M Buy
28,014
+781
+3% +$87K 0.33% 57
2019
Q2
$3.02M Sell
27,233
-3,048
-10% -$359K 0.31% 55
2019
Q1
$3.93M Buy
30,281
+6,917
+30% +$841K 0.37% 46
2018
Q4
$2.7M Buy
+23,364
New +$2.61M 0.37% 51

Other funds holding LLY

Seeyond's LLY Position: Q4 2022 in Review

Seeyond increased its Eli Lilly (LLY) stake by 26% in Q4 2022, buying an estimated $1.07M and bringing the position to 14,606 shares worth $5.34M. The position accounts for 0.52% of the portfolio, ranked #34.

Seeyond first reported a position in LLY in Q4 2018 and has held it in 17 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Seeyond held 14,606 shares of Eli Lilly worth $5.34M as of Q4 2022.
  • Seeyond bought 3,005 Eli Lilly shares in Q4 2022, an estimated $1.07M.
  • Eli Lilly made up 0.52% of Seeyond's portfolio in Q4 2022, its #34 holding.
  • Seeyond first reported a position in Eli Lilly in Q4 2018 and has held it in 17 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.